Journal
GYNECOLOGIC ONCOLOGY
Volume 158, Issue 1, Pages 34-36Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2020.04.703
Keywords
SARS-CoV-2; COVID-19; Ovarian cancer; Oral; Targeted therapy